Medtronic (MDT) reported fiscal third-quarter results that exceeded Wall Street expectations, posting earnings per share of $1.45 against a consensus estimate of $1.39. This represents a positive surprise of 4.51%, primarily attributed to robust revenue growth of nearly 9.9% year-on-year. The company’s ability to maintain margin expansion despite macro-headwinds has been favouring investor sentiment, although the headline figures mask underlying headwinds in its core implantable cardioverter-defibrillator segment.
Tag: MDT
MDT forms Cup with Handle near pivot; Stage 3 topping keeps sentiment neutral
Medtronic (MDT) is tracing a 38-week Cup with Handle base, with the handle currently resolving near its 94.13 pivot after a shallow 4.4% pullback. However, […]